Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-23-003567
Filing Date
2023-02-28
Accepted
2023-02-28 20:14:03
Documents
2
Period of Report
2023-02-26

Document Format Files

Seq Description Document Type Size
1 form3-03012023_010342.html 3  
1 form3-03012023_010342.xml 3 1665
2 ex24-03012023_010342.htm EX-24 6330
  Complete submission text file 0001415889-23-003567.txt   9364
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Issuer) CIK: 0001583107 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10770 WATERIDGE CIRCLE SUITE 200 SAN DIEGO CA 92121
Business Address
GRAY SUSANNAH (Reporting) CIK: 0001833453 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36033 | Film No.: 23689000